3628 results for «328»
3628 results
Transcatheter mitral valve interventions: procedural considerations
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch these presentations regarding transcatheter mitral valve interventions to learn how to select patients for each potential therapy and how to guide inside the cathlab.
Transcatheter tricuspid valve interventions: procedural considerations
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on transcatheter tricuspid valve interventions to know more about what to do before planning tricuspid regurgitation interventions, to understand when to perform a right heart catheterisation and to learn how to solve complications during interventions.
Diagnosis and classification of tricuspid regurgitation
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the anatomy of the tricuspid valve and its challenges, to know when and how to treat tricuspid regurgitation, and to discover all about the latest classification regarding this condition.
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
The impact of COVID-19 pandemic on interventional cardiologists in training
23 Oct 2020
In collaboration with EuroIntervention Journal
The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...
ACC 2019 Day 1: PARTNER 3, Evolut Low Risk Trial and Apple Heart Study
17 Mar 2019
Mirvat Al Asnag reports live on three late-breaking trials presented at ACC 2019: PARTNER 3, Evolut Low Risk Trial and the Apple Heart Study
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
03 Sep 2025
Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.
Author
